The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative ...

AMSTERDAM (Reuters) - The European Medicines Agency (EMA) said on Monday it would ... as it decided on the use of vaccines in the European Union. The European Commission and other EU institutions ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

AMSTERDAM (Reuters) - The European Medicines Agency (EMA) said on Monday it would no longer post ... as it decided on the use of vaccines in the European Union. The European Commission and other EU ...

1 Christoffersen M et al. Transthyretin Tetramer Destabilization and Increased Mortality in the General Population. JAMA ...

Business debate on research and innovation (R&I) funding in the EU’s new mandate, global health leaders underlined the ...

Imfinzi recommended for approval in European Union for the treat of adults with limited-stage small cell lung cancer ...

Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (Nasdaq Stockholm: EGTX), today announced that the European Commission (EC) has approved Emcitate® (tiratricol) ...

CSL has received approval from the European Commission (EC) for Andembry (garadacimab) to prevent recurrent attacks of ...